Replies to post #628129 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

brazen22,

You are never going to see the FDA or MHRA allow trials to treat patients like lab rats.

If you prefer a randomized placebo design, then you’ll love the pembrolizumab PD1 blockade combo study that is ongoing at UCLA today. The study has a placebo design because the placebo participants are receiving DCVax-L as the best available therapy for rGBM.

https://classic.clinicaltrials.gov/ct2/show/NCT04201873

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/